Back to search
FDAFDA · Food and drugs·Recall number D-0032-2018

MAN OF STEEL capsules, 3000mgs/grain, 1-count packets, Packaged for: One Drop Solutions, LLC, POB 231693, Sacramento, California 95823; vitility@yahoo.com; www.manofsteelpills.com; UPC 1 0001001378 7.

Published November 1, 2017 · Recall initiated: June 22, 2017

Summary

FDA records drug Class I recall D-0032-2018, published November 1, 2017 and initiated June 22, 2017. Recalling firm: Vitility; Status: Terminated; Reported quantity: 75 packets; Lot: No Lot #: labeled Expires: 10-17-2018. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Vitility
Distributor
Nationwide in the USA
Lot
No Lot #: labeled Expires: 10-17-2018
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was MAN OF STEEL capsules, 3000mgs/grain, 1-count packets, Packaged for: One Drop Solutions, LLC, POB 231693, Sacramento, California 95823; vitility@yahoo.com; www.manofsteelpills.com; UPC 1 0001001378 7. recalled?

Yes. FDA published recall D-0032-2018 on November 1, 2017. Reported hazard: Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release